BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37277320)

  • 1. Patient-initiated follow-up in women with early-stage endometrial cancer: A long-term follow-up of the OPAL trial.
    Rulanda MC; Mogensen O; Jensen PT; Hansen DG; Wu C; Jeppesen MM
    BJOG; 2023 Dec; 130(13):1593-1601. PubMed ID: 37277320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-initiated follow up affects fear of recurrence and healthcare use: a randomised trial in early-stage endometrial cancer.
    Jeppesen MM; Jensen PT; Hansen DG; Christensen RD; Mogensen O
    BJOG; 2018 Dec; 125(13):1705-1714. PubMed ID: 29978593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient initiated follow up in Obstetrics and Gynaecology: A systematic review.
    Kershaw VF; Chainrai M; Radley SC
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():123-129. PubMed ID: 35303674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the acceptability and feasibility of patient-initiated follow-up for women treated for stage I endometrial cancer.
    Beaver K; Martin-Hirsch P; Williamson S; Kyrgiou M
    Eur J Oncol Nurs; 2020 Feb; 44():101704. PubMed ID: 31812918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Initiated Follow-Up in Ovarian Cancer.
    Luk HM; Ngu SF; Lau LSK; Tse KY; Chu MMY; Kwok ST; Ngan HYS; Chan KKL
    Curr Oncol; 2023 Mar; 30(4):3627-3636. PubMed ID: 37185389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial.
    Janda M; Gebski V; Brand A; Hogg R; Jobling TW; Land R; Manolitsas T; McCartney A; Nascimento M; Neesham D; Nicklin JL; Oehler MK; Otton G; Perrin L; Salfinger S; Hammond I; Leung Y; Walsh T; Sykes P; Ngan H; Garrett A; Laney M; Ng TY; Tam K; Chan K; Wrede CD; Pather S; Simcock B; Farrell R; Obermair A
    Lancet Oncol; 2010 Aug; 11(8):772-80. PubMed ID: 20638899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does fear of cancer recurrence differ between cancer types? A study from the population-based PROFILES registry.
    van de Wal M; van de Poll-Franse L; Prins J; Gielissen M
    Psychooncology; 2016 Jul; 25(7):772-8. PubMed ID: 26464337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient initiated follow up after gynaecological malignancy: National survey of current UK practice.
    Coleman L; Newton C
    Eur J Obstet Gynecol Reprod Biol; 2020 May; 248():193-197. PubMed ID: 32240892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing hospital and telephone follow-up for patients treated for stage-I endometrial cancer (ENDCAT trial): a randomised, multicentre, non-inferiority trial.
    Beaver K; Williamson S; Sutton C; Hollingworth W; Gardner A; Allton B; Abdel-Aty M; Blackwood K; Burns S; Curwen D; Ghani R; Keating P; Murray S; Tomlinson A; Walker B; Willett M; Wood N; Martin-Hirsch P
    BJOG; 2017 Jan; 124(1):150-160. PubMed ID: 27062690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy for women previously treated for endometrial cancer.
    Edey KA; Rundle S; Hickey M
    Cochrane Database Syst Rev; 2018 May; 5(5):CD008830. PubMed ID: 29763969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
    de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; D'Amico R; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Gribaudo S; Provencher D; Hanzen C; Kruitwagen RF; Smit VTHBM; Singh N; Do V; Lissoni A; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL;
    Lancet Oncol; 2019 Sep; 20(9):1273-1285. PubMed ID: 31345626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
    de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; Colombo A; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Carinelli S; Provencher D; Hanzen C; Lutgens LCHW; Smit VTHBM; Singh N; Do V; D'Amico R; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL;
    Lancet Oncol; 2018 Mar; 19(3):295-309. PubMed ID: 29449189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-initiated follow-up after treatment for low risk endometrial cancer: a prospective audit of outcomes and cost benefits.
    Coleridge S; Morrison J
    Int J Gynecol Cancer; 2020 Aug; 30(8):1177-1182. PubMed ID: 32376734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ENdometrial cancer SURvivors' follow-up carE (ENSURE): Less is more? Evaluating patient satisfaction and cost-effectiveness of a reduced follow-up schedule: study protocol of a randomized controlled trial.
    Ezendam NPM; de Rooij BH; Kruitwagen RFPM; Creutzberg CL; van Loon I; Boll D; Vos MC; van de Poll-Franse LV
    Trials; 2018 Apr; 19(1):227. PubMed ID: 29661218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of recurrence in early stage endometrial cancer - the role of symptoms and routine follow-up.
    Jeppesen MM; Mogensen O; Hansen DG; Iachina M; Korsholm M; Jensen PT
    Acta Oncol; 2017 Feb; 56(2):262-269. PubMed ID: 28080157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-initiated follow-up in gynaecology: Patient and clinician views.
    Chainrai M; Kershaw VF; Gray TG; Radley SC
    Eur J Obstet Gynecol Reprod Biol; 2024 Jul; 298():18-22. PubMed ID: 38705009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability and utilisation of patient-initiated follow-up for endometrial cancer amongst women from diverse ethnic and social backgrounds: A mixed methods study.
    Kumarakulasingam P; McDermott H; Patel N; Boutler L; Tincello DG; Peel D; Moss EL
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12997. PubMed ID: 30748056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for advanced endometrial cancer.
    Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A correlation study of fear of cancer recurrence, illness representation, self-regulation, and quality of life among gynecologic cancer survivors in Taiwan.
    Tsai LY; Lee SC; Wang KL; Tsay SL; Tsai JM
    Taiwan J Obstet Gynecol; 2018 Dec; 57(6):846-852. PubMed ID: 30545539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Romero SA; Young K; Hickey M; Su HI
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.